Suppr超能文献

亲水基团如何影响药物-蛋白结合模式:Sirtuins 抑制剂 Tenovin-1/Tenovin-6 与人血清白蛋白相互作用的差异。

How hydrophilic group affects drug-protein binding modes: Differences in interaction between sirtuins inhibitors Tenovin-1/Tenovin-6 and human serum albumin.

机构信息

School of Chemical Engineering, Sichuan University, Chengdu, 610065, Sichuan, China.

School of Chemical Engineering, Sichuan University, Chengdu, 610065, Sichuan, China.

出版信息

J Pharm Biomed Anal. 2021 Jul 15;201:114121. doi: 10.1016/j.jpba.2021.114121. Epub 2021 May 7.

Abstract

Introduction of hydrophilic groups can improve the solubility of leading drugs but inevitably affect their interaction with proteins. This study selected sirtuin inhibitors Tenovin-1 (T1) and Tenovin-6 (T6) as drug models to determine differences in binding mode to human serum albumin (HSA). T1 and T6 quenched the endogenous fluorescence of HSA via static quenching mechanism. Introduction of hydrophilic groups greatly reduced the binding constant, i.e., from 1.302 × 10 L mol for the HSA-T6 system to 0.128 × 10 L mol for the HSA-T1 system. HSA-T1 system was mainly driven by electrostatic interactions while that of HSA-T6 system was hydrophobic interaction and both systems were spontaneous reactions. Site marker experiments and molecular docking indicated that both systems mainly bound to the hydrophobic site I of HSA. Molecular dynamics (MD) simulation analysis further revealed that Tyr148, Tyr150 and Arg257 residues played a key role in this recognition process for both systems. In particular, T6 maintained additional several hydrogen bonds with the surrounding residues. T1 had almost no effect on the esterase-like activity of HSA, but T6 inhibited the hydrolysis of p-NPA. Furthermore, differential scanning calorimetry (VP-DSC), circular dichroism (CD) and Fourier transform infrared (FTIR) spectroscopy confirmed that HSA in the T6 system undergone a more significant conformational transition than that in the T1 system.

摘要

介绍亲水基团可以提高先导药物的溶解度,但不可避免地会影响它们与蛋白质的相互作用。本研究选择 Sirtuin 抑制剂 Tenovin-1(T1)和 Tenovin-6(T6)作为药物模型,以确定它们与人血清白蛋白(HSA)结合模式的差异。T1 和 T6 通过静态猝灭机制猝灭了 HSA 的内源性荧光。引入亲水基团大大降低了结合常数,即从 HSA-T6 体系的 1.302×10 L mol 降低到 HSA-T1 体系的 0.128×10 L mol。HSA-T1 体系主要由静电相互作用驱动,而 HSA-T6 体系主要由疏水相互作用驱动,两个体系均为自发反应。位点标记实验和分子对接表明,两个体系主要结合 HSA 的疏水结合位点 I。分子动力学(MD)模拟分析进一步表明,两个体系均通过 Tyr148、Tyr150 和 Arg257 残基与周围残基形成氢键,对这种识别过程起关键作用。特别是 T6 与周围残基保持额外的几个氢键。T1 对 HSA 的酯酶样活性几乎没有影响,但 T6 抑制了 p-NPA 的水解。此外,差示扫描量热法(VP-DSC)、圆二色性(CD)和傅里叶变换红外(FTIR)光谱证实,与 T1 体系相比,T6 体系中的 HSA 经历了更显著的构象转变。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验